CLIMB BIO, INC. Increase Decrease In Operating Lease Liability
CLIMB BIO, INC. (CLYM) reported Increase Decrease In Operating Lease Liability of $5.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-06
- CLIMB BIO, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was $67.00K.
- CLIMB BIO, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$62.00K.
- CLIMB BIO, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$39.00K.
- CLIMB BIO, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$59.00K.
- CLIMB BIO, INC. increase decrease in operating lease liability for fiscal 2025 was -$207.00K.
- CLIMB BIO, INC. increase decrease in operating lease liability for fiscal 2024 was -$327.00K.
- CLIMB BIO, INC. increase decrease in operating lease liability for fiscal 2023 was -$444.00K.
- CLIMB BIO, INC. increase decrease in operating lease liability for fiscal 2022 was -$447.00K.
| Period end | Increase Decrease In Operating Lease Liability | Increase Decrease In Operating Lease Liability 1 month | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $5.00K 10-Q · filed 2026-08-06 | -$34.00K derived: sum of 3 quarters · filed 2026-08-06 | -$93.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | -$62.00K 10-Q · filed 2026-05-07 | -$101.00K derived: sum of 2 quarters · filed 2026-05-07 | -$160.00K derived: sum of 3 quarters · filed 2026-05-07 | -$210.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | -$39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$98.00K derived: sum of 2 quarters · filed 2026-03-05 | -$148.00K derived: sum of 3 quarters · filed 2026-08-06 | -$207.00K 10-K · filed 2026-03-05 | ||
| 2025-09-30 | -$59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$109.00K derived: sum of 2 quarters · filed 2026-08-06 | -$168.00K 10-Q · filed 2025-11-06 | -$204.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | -$50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$109.00K 10-Q · filed 2026-08-06 | -$145.00K derived: sum of 3 quarters · filed 2026-08-06 | -$187.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-04-30 | $200.00K 10-Q · filed 2025-11-06 | $200.00K 10-K · filed 2026-03-05 | ||||
| 2025-03-31 | -$59.00K 10-Q · filed 2026-05-07 | -$95.00K derived: sum of 2 quarters · filed 2026-05-07 | -$137.00K derived: sum of 3 quarters · filed 2026-05-07 | -$262.00K derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | -$36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$78.00K derived: sum of 2 quarters · filed 2026-03-05 | -$203.00K derived: sum of 3 quarters · filed 2026-03-05 | -$327.00K 10-K · filed 2026-03-05 | ||
| 2024-09-30 | -$42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$167.00K derived: sum of 2 quarters · filed 2025-11-06 | -$291.00K 10-Q · filed 2025-11-06 | -$401.00K derived: sum of 4 quarters · filed 2025-11-06 | ||
| 2024-06-30 | -$125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$249.00K 10-Q · filed 2025-08-12 | -$359.00K derived: sum of 3 quarters · filed 2025-08-12 | -$484.00K derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | -$124.00K 10-Q · filed 2025-05-14 | -$234.00K derived: sum of 2 quarters · filed 2025-05-14 | -$359.00K derived: sum of 3 quarters · filed 2025-05-14 | -$461.00K derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | -$110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | -$235.00K derived: sum of 2 quarters · filed 2025-03-25 | -$337.00K derived: sum of 3 quarters · filed 2025-03-25 | -$444.00K 10-K · filed 2025-03-25 | ||
| 2023-09-30 | -$125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$227.00K derived: sum of 2 quarters · filed 2024-11-12 | -$334.00K 10-Q · filed 2024-11-12 | -$425.00K derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | -$102.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$209.00K 10-Q · filed 2024-08-14 | -$300.00K derived: sum of 3 quarters · filed 2024-08-14 | -$425.00K derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | -$107.00K 10-Q · filed 2024-05-15 | -$198.00K derived: sum of 2 quarters · filed 2024-05-15 | -$323.00K derived: sum of 3 quarters · filed 2024-05-15 | -$465.00K derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | -$91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$216.00K derived: sum of 2 quarters · filed 2024-03-28 | -$358.00K derived: sum of 3 quarters · filed 2024-03-28 | -$447.00K 10-K · filed 2024-03-28 | ||
| 2022-09-30 | -$125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$267.00K derived: sum of 2 quarters · filed 2023-11-14 | -$356.00K 10-Q · filed 2023-11-14 | -$356.00K derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | -$142.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$231.00K 10-Q · filed 2023-08-10 | -$231.00K derived: sum of 3 quarters · filed 2023-08-10 | -$231.00K derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | -$89.00K 10-Q · filed 2023-05-11 | -$89.00K derived: sum of 2 quarters · filed 2023-05-11 | -$89.00K derived: sum of 3 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $0.00 derived: sum of 2 quarters · filed 2023-03-06 | $0.00 10-K · filed 2023-03-06 | |||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |